MAP2K7 and ovarian carcinoma: This is consistent with the previously reported mechanism of MEK/ERK/p90RSK pathway regulation of cell-cycle progression and migration52, 53, 54, 55, further indicating that MEK mediates MAP3K8 effects on the proliferation and motility of ovarian cancer cells.